As monotherapy , a multicentre, randomised, double-blind, placebo-controlled and active-controlled Phase 2 dose-finding trial enrolled 706 adults with overweight or obesity (without diabetes) to once-weekly subcutaneous cagrilintide across doses of 0.3 to 4.5 mg over 26 weeks
Other rare symptoms may include irritability, microcephaly, autism spectrum disorder, tremor, global developmental delay, coma, polyneuropathy, axial hypotonia, and daytime sleepiness [100, 102,103,104,105,106,107,108]
While its accessible and affordable, absorption can be limited since glutathione gets broken down during digestion
Sep 2025;6(9):e70241
Just like any other supplement, its important to discuss with your healthcare provider before you take it, Malhotra says
Exposure to toxic heavy metals is believed to be a contributing factor, if not a root cause, of symptoms like low energy, mood disturbances and cognitive changes